168 related articles for article (PubMed ID: 18950580)
1. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
4. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
Iizuka K; Horikawa Y
Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
[TBL] [Abstract][Full Text] [Related]
5. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
Iizuka K
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
[TBL] [Abstract][Full Text] [Related]
6. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
[TBL] [Abstract][Full Text] [Related]
8. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
9. Role of ChREBP in hepatic steatosis and insulin resistance.
Denechaud PD; Dentin R; Girard J; Postic C
FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
[TBL] [Abstract][Full Text] [Related]
10. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
11. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.
Beaven SW; Matveyenko A; Wroblewski K; Chao L; Wilpitz D; Hsu TW; Lentz J; Drew B; Hevener AL; Tontonoz P
Cell Metab; 2013 Jul; 18(1):106-17. PubMed ID: 23823481
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
14. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
15. [The transcription factor ChREBP: a key modulator of insulin sensitivity?].
Benhamed F; Poupeau A; Postic C
Med Sci (Paris); 2013; 29(8-9):765-71. PubMed ID: 24005632
[TBL] [Abstract][Full Text] [Related]
16. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload.
Agius L
Biochem Pharmacol; 2013 Feb; 85(3):306-12. PubMed ID: 23022226
[TBL] [Abstract][Full Text] [Related]
17. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
Postic C; Girard J
J Clin Invest; 2008 Mar; 118(3):829-38. PubMed ID: 18317565
[TBL] [Abstract][Full Text] [Related]
18. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
[TBL] [Abstract][Full Text] [Related]
19. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
